![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1442, 2004-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An amended lawsuit has been filed against pharmaceutical giant GlaxoSmithKline
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lamivudine/abacavir [Kivexa; GlaxoSmithKline] has been launched in the UK and Germany
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The UK MHRA is to reclassify sumatriptan [Imigran Recovery; GlaxoSmithKline]
Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Big Three of US Pharma: Pfizer, Merck & Co. and GlaxoSmithKline
Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. :